State Medicaid programs continue to restrict access to hepatitis C drugs
(By Ed Silverman for STAT) Over the past two years, state Medicaid programs have done a better job of disclosing
Read More
Health Care – General
DNA Is Not Destiny When It Comes To Heart Risk
(By Richard Harris for NPR) You can’t choose your parents, so you can’t help it if you’re born with genes
Read MoreVietnam Vets and Rare Form of Cancer
Ralph Erickson, who heads post-deployment health services at the Department of Veterans Affairs said about 700 Cholangiocarcinoma (caused by parasites
Read MoreAging and Affordable Housing
In a recent report by the Bipartisan Policy Center’s Senior Health and Housing Task Force, we are unprepared for the
Read MoreWhat does Donald Trump’s win mean for science and medicine?
(By Damian Garde for STAT) It’s hard to escape the din of the nation’s prognostication industry coming to terms with
Read MoreTrump, GOP In Congress Could Use “Must-Pass” Bills To Bring Health Changes
(By Julie Rovner for Kaiser Health News) Throughout the campaign, President-Elect Donald Trump’s entire health message consisted of promising to
Read MoreNovel system to get dying patients an experimental cancer drug raises hopes — and thorny questions
(By Karen Weintraub for STAT) The drug was still experimental, but clinical trials suggested it could be a lifesaver for
Read MoreThis drug discount program is good for Americans. But pharma wants to gut it
(By Ted Slafsky for STAT) Sticker shock over the cost of drugs isn’t going away any time soon. Drug prices
Read MoreWhat clinical trial results? Now you can see who isn’t sharing their findings
(By Ed Silverman for STAT) The results for nearly half of all clinical trials conducted by big drug makers during
Read MoreAnxious about your health? You might be at greater risk for heart disease
(By Eric Boodman for STAT) Being worried sick is more than just a figure of speech. It’s also a medical
Read More